The findings indicated that high INKA2-AS1 expression was found in 14 tumors, including ACC, CHOL, GBM, HNSC, LAML, LGG, PAAD, PCPG, SARC, and THYM (Figures 3(a) and 3(b)). Here, INKA2 is linked to adrenal cortex carcinoma.